Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathway

Abstract

Thapsigargin (TG), by inducing perturbations in cellular Ca2+ homeostasis, has been shown to induce apoptosis. The molecular mechanisms of Ca2+ perturbation-induced apoptosis are not fully understood. In this study, we demonstrate for the first time that TG-mediated perturbations in Ca2+ homeostasis are coupled with activation of the death receptor 5 (DR5)-dependent apoptotic pathway in human cancer cells. TG selectively upregulated DR5 but had no effect on the expression of the other TRAIL receptor, DR4. TG also upregulated the expression of the DR5 ligand TRAIL (tumor necrosis factor-related apoptosis inducing ligand), albeit in a cell-type specific manner. TG-induced apoptosis has been shown to be associated with activation of the mitochondrial pathway. We found that TG upregulation of DR5 and TRAIL was coupled with caspase 8 activation and Bid cleavage, suggesting that the TG-regulated DR5 pathway could be linked to the mitochondrial pathway. TG enhanced not only DR5 mRNA stability but also increased induction of the DR5 genomic promoter-reporter gene. The TG-induced increase in DR5 expression appeared to occur as a consequence of TG-induced endoplasmic reticulum (ER) Ca2+ pool depletion. Thus, we report our novel findings that ER Ca2+ pool depletion-induced apoptotic signals are mediated, at least in part, via a DR5-dependent apoptotic pathway and there appears to be a cross-talk between the death receptor and mitochondrial pathways.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8
Figure 9
Figure 10
Figure 11
Figure 12

Similar content being viewed by others

References

  • Ashkenazi A, Dixit VM . 1999 Curr. Opin. Cell Biol. 11: 255–260

  • Chen CY, Shyu AB . 1995 Trends Biochem. Sci. 20: 465–470

  • Furuya Y, Lundmo P, Short AD, Gill DL, Isaacs JT . 1994 Cancer Res. 54: 6167–6175

  • Griffith TS, Rauch CT, Smolak PJ, Waugh JY, Boiani N, Lynch D, Smith CA, Goodwin RG, Kubin MZ . 1999 J. Immunol. 176: 2597–2605

  • Gross A, McDonnell JM, Korsmeyer SJ . 2000 Genes Dev. 13: 1899–1911

  • Huang Y, He Q, Hillman MJ, Rong R, Sheikh MS . 2001 Cancer Res. 61: 6918–6924

  • Jackman J, Alamo Jr I, Fornace Jr AJ . 1994 Cancer Res. 54: 5656–5662

  • Kaufman RJ . 1999 Genes Dev. 13: 1211–1233

  • Krebs J . 1998 BioMetals. 11: 375–382

  • Li H, Zhu H, Xu CJ, Yuan J . 1998 Cell 94: 491–501

  • Li WW, Alexandre S, Cao X, Lee AS . 1993 J. Biol. Chem. 268: 12003–12009

  • Luo X, Budihardjo I, Zou H, Slaughter C, Wang X . 1998 Cell 94: 481–490

  • Orth K, O'Rourke K, Salvesen GS, Dixit VM . 1996 J. Biol. Chem. 271: 20977–20980

  • Ron D, Habener JF . 1992 Genes Dev. 6: 439–453

  • Ruth JH, Esnault S, Jarzembowski JA, Malter JS . 1999 Am. J. Respir. Cell Mol. Biol. 21: 621–628

  • Sagara Y, Inesi G . 1991 J. Biol. Chem. 266: 13503–13506

  • Schulze-Osthoff K, Ferrari D, Los M, Wesselborg S, Peter ME . 1998 Eur. J. Biochem. 254: 439–459

  • Sheikh MS, Li XS, Chen JC, Shao ZM, Ordonez JV, Fontana JA . 1994 Oncogene 9: 3407–3415

  • Sheikh MS, Burns TF, Huang Y, Wu GS, Amundson S, Brooks KS, Fornace Jr AJ, El-Deiry WS . 1998a Cancer Res. 58: 1593–1598

  • Sheikh MS, Antinore MJ, Huang Y, Fornace Jr AJ . 1998b Oncogene 17: 2555–2563

  • Sheikh MS, Fornace Jr AJ . 2000 Leukemia 14: 1509–1513

  • Takimoto R, El-Deiry WS . 2000 Oncogene 19: 1735–1743

  • Thornberry NA, Lazebnik Y . 1998 Science 281: 1312–1316

  • Waser M, Mesaeli N, Spencer C, Michalak M . 1997 J. Cell Biol. 138: 547–557

  • Wertz IE, Dixit VM . 2000 J. Biol. Chem. 275: 11470–11477

  • Wei MC, Lindsten T, Mootha VK, Weiler S, Gross A, Ashiya M, Thompson CB, Korsmeyer SJ . 2000 Genes Dev. 14: 2060–2071

  • Wu GS, Burns TF, McDonald III ER, Jiang W, Meng R, Krantz ID, Kao G, Gan DD, Zhou J-Y, Muschel R, Hamilton SR, Spinner NB, Markowitz S, Wu G, El-Deiry WS . 1997 Nat. Genet. 171: 141–143

  • Zhan Q, Fan S, Smith ML, Bae I, Yu K, Alamo Jr I, O'Connor PM, Fornace Jr AJ . 1996 DNA Cell Biol. 15: 805–815

Download references

Acknowledgements

Part of this work was initiated at the NCI/NIH and MS Sheikh thanks Ms Kia Brooks for help with the Northern blot analyses. This work was supported in part by United States Army Prostate Cancer Research Program grant DAMD 170010722 and NIH grant CA89043 to MS Sheikh and a Merit Review Award from the Medical Research Services of the Department of Veterans Affairs to A Hussain and National Institutes of Health Grant PO1HL27867.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Saeed Sheikh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

He, Q., Lee, D., Rong, R. et al. Endoplasmic reticulum calcium pool depletion-induced apoptosis is coupled with activation of the death receptor 5 pathway. Oncogene 21, 2623–2633 (2002). https://doi.org/10.1038/sj.onc.1205345

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205345

Keywords

This article is cited by

Search

Quick links